Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of sublingual dexmedetomidine for the treatment of agitation

Use of sublingual dexmedetomidine for the treatment of agitation

US Patent 11931340 · Granted Mar 19, 2024

Estimated economic value: $2,892,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Non-sedating dexmedetomidine treatment regimens2025
Non-sedating dexmedetomidine treatment regimens2024
Non-sedating dexmedetomidine treatment regimens2024
Non-sedating dexmedetomidine treatment regimens2024
Non-sedating dexmedetomidine treatment regimens2024
Non-sedating dexmedetomidine treatment regimens2024
Non-sedating dexmedetomidine treatment regimens2024
Use of sublingual dexmedetomidine for the treatment of agitation2023
Use of sublingual dexmedetomidine for the treatment of agitation2023
Use of sublingual dexmedetomidine for the treatment of agitation2023
Use of sublingual dexmedetomidine for the treatment of agitation2023
Use of sublingual dexmedetomidine for the treatment of agitation2023